The future of the drug was called into question after a Texas judge sought to invalidate its long standing approval.
The case comes after the Supreme Court which has 6-3 conservative super-majority overturned Roe v Wade in June last year ending the nation wide guarantee to abortion and giving states the power to ban the procedure.
Following Friday’s ruling, the Mifepristone case now returns to the lower 5th circuit Courts of Appeals and it’s likely that the case will come before the Supreme Court once again setting up the most significant ruling on the issue of abortion since Roe was overturned.
Mifepristone is part of a two drug regimen that now accounts for more than half of abortions in the country and it has been more than five million women in the US to terminate their pregnancies.
Matthew Kacsmaryk had ruled to suspend Mifepristone approval
It was first approved by the US food and drug administration more than 20 years ago after four years of review and it placed Mifepristone in a category of 60 drugs that are regulated under a system of extra restrictions and regular evaluations.
Earlier this month, the Texas court Matthew Kacsmaryk had ruled to suspend the FDA approval of mifepristone saying the agency had violated federal rules that allowed for the accelerated approval of some drugs and had erred in its scientific assessments of the drug.
His preliminary decision come after a group of anti abortion health professionals launched a case challenging the safety of mifepristone.
The 7 April ruling was made just minutes before a decision from a judge in Washington state ordered the FDA to make no change to the drug’s availability and preserving access to mifepristone in 17 US states.
Two of the Supreme Court’s conservative members, justice Clarence Thomas and Justice Samuel Alito dissented publicly to the decision which come in a single paragraph issued hours before a self imposed deadline.
Check also;
- US Federal Judge Halts Approval Of Abortion Pill
- HIV Drugs Run Out Of Stock, Causes Panic People Living With HIV
Please use the button below to contribute to Newslex Point, Inc. using a credit card or via PayPal.